ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INSD, MZKR

Author's Avatar
Feb 09, 2022

PR Newswire